DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
14.94
+0.01 (0.07%)
At close: Mar 31, 2025, 4:00 PM
15.14
+0.20 (1.36%)
Pre-market: Apr 1, 2025, 5:55 AM EDT
DENTSPLY SIRONA Revenue
In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%. DENTSPLY SIRONA had revenue of $905.00M in the quarter ending December 31, 2024, a decrease of -10.57%.
Revenue (ttm)
$3.79B
Revenue Growth
-4.34%
P/S Ratio
0.80
Revenue / Employee
$270,929
Employees
14,000
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
XRAY News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Investors to Reach Out - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out - Accesswire
- 7 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect - Accesswire
- 11 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 14 days ago - Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader - GlobeNewsWire